BIOMAT Database Logo BIOMAT Database Logo

Poliovirus antibody status after vaccination with trivalent oral vaccine. 1976

R Clara, and A Deprettere, and D van der Berghe, and S Pattyn

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Poliovirus antibody status three years after vaccination with trivalent oral vaccine.
September 1970, Acta paediatrica Scandinavica,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Serum antibody levels after immunization with trivalent oral poliovirus vaccine.
February 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Antibody persistence after primary immunization with trivalent oral poliovirus vaccine.
July 1977, Pediatrics,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
PERSISTENCE OF ANTIBODY AFTER ORAL TRIVALENT POLIOVIRUS VACCINE (SABIN STRAINS).
February 1964, The New England journal of medicine,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
POLIOVIRUS ANTIBODY TWO YEARS AFTER ORAL TRIVALENT VACCINE (SABIN STRAINS).
October 1964, JAMA,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
September 2009, The Journal of infectious diseases,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Poliovirus antibody status and the response to trivalent oral poliovirus vaccine in Norwegian school children.
September 1968, Acta paediatrica Scandinavica,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Early immunization of neonates with trivalent oral poliovirus vaccine.
January 1992, Bulletin of the World Health Organization,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
November 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
R Clara, and A Deprettere, and D van der Berghe, and S Pattyn
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
August 2018, The New England journal of medicine,
Copied contents to your clipboard!